Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancerTakaaki Mizuno, Kenji Tamura|Oncology Letters|2020Cited by 21
HER3 protein expression as a risk factor for post‑operative recurrence in patients with early‑stage adenocarcinoma and adenosquamous carcinoma of the cervixTakaaki Mizuno, Kenji Tamura|Oncology Letters|2020Cited by 10